Wednesday, August 14, 2013

Reuters: Health News: Pharmstandard to buy ingredient supplier for $590 million

Pharmstandard to buy ingredient supplier for $590 million

MOSCOW (Reuters) - Russian drugmaker Pharmstandard has agreed to buy a supplier of ingredients for its flagship anti-viral and anxiety drugs for $590 ...

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/NFV57G4AorA/story01.htm


No comments:

Post a Comment

Subscribe Now: Feed Icon